Financiere Des Professionnels Fonds D,Investissement Inc. Biomarin Pharmaceutical Inc Transaction History
Financiere Des Professionnels Fonds D,Investissement Inc.
- $1.74 Trillion
- Q3 2025
A detailed history of Financiere Des Professionnels Fonds D,Investissement Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Financiere Des Professionnels Fonds D,Investissement Inc. holds 19,329 shares of BMRN stock, worth $1.04 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
19,329Holding current value
$1.04 Million% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding BMRN
# of Institutions
691Shares Held
187MCall Options Held
1.31MPut Options Held
1.1M-
Black Rock Inc. New York, NY22.7MShares$1.22 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.02 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$845 Million0.71% of portfolio
-
Dodge & Cox San Francisco, CA15.1MShares$809 Million0.5% of portfolio
-
Viking Global Investors LP12.3MShares$658 Million2.14% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $9.95B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...